Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

epratuzumab

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00044902 - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) | Biotech Hunter | Biotech Hunter